Edition:
United States

Yabao Pharmaceutical Group Co Ltd (600351.SS)

600351.SS on Shanghai Stock Exchange

7.10CNY
21 Sep 2018
Change (% chg)

¥0.06 (+0.85%)
Prev Close
¥7.04
Open
¥7.04
Day's High
¥7.12
Day's Low
¥7.04
Volume
5,422,302
Avg. Vol
8,287,386
52-wk High
¥8.94
52-wk Low
¥6.02

Latest Key Developments (Source: Significant Developments)

Yabao Pharma Sees 2017 Net Profit Up 788-818 Pct On Rising Sales Of High Margin Products
Monday, 25 Dec 2017 03:50am EST 

Dec 25 (Reuters) - Yabao Pharmaceutical Group Co Ltd <600351.SS>::SAYS IT SEES 2017 NET PROFIT UP 788-818 PERCENT Y/Y FROM 225.2 MILLION YUAN ($34.44 million) YEAR AGO.  Full Article

Yabao Pharmaceutical Group sees 2017 Q1-Q3 net profit to increase by 100 pct to 120 pct
Tuesday, 26 Sep 2017 11:37pm EDT 

Sept 27(Reuters) - Yabao Pharmaceutical Group Co Ltd <600351.SS> ::* Says net profit for 2017 Q1-Q3 to increase by 100 percent to 120 percent, compared to net profit of 2016 Q1-Q3 (68.8 million yuan).* Says increased sales revenue as main reason for the forecast.  Full Article

Yabao Pharmaceutical Group gets approval to conduct drug clinical trials for diabetes
Monday, 31 Jul 2017 01:09am EDT 

July 29 (Reuters) - Yabao Pharmaceutical Group Co Ltd <600351.SS>:* Says it gets an approval to conduct drug clinical trials of SY-008 which can be used for treatment of diabetes, from China Food and Drug Administration.  Full Article

Yabao Pharmaceutical Group sees FY 2016 net profit down 70 pct to 90 pct
Monday, 23 Jan 2017 03:56am EST 

Yabao Pharmaceutical Group <600351.SS> :Says it sees 2016 net profit down 70 percent to 90 percent, from a year ago.  Full Article

Yabao Pharmaceutical Group sees 2016 Q1~Q3 net profit to decrease by 50 pct to 70 pct
Wednesday, 12 Oct 2016 06:02am EDT 

Yabao Pharmaceutical Group Co Ltd <600351.SS> :sees 2016 Q1~Q3 net profit to decrease by 50 percent to 70 percent, compared to net profit of Q1~Q3 in 2015(206.7 million yuan).  Full Article